Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

HDM1005

Phase Ib Clinical Study of HDM1005 Injection

Huadong Medicine · Phase 1 · Completed · Enrollment 80

NCT06637020

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
HDM1005 injection dose level 1(Part 1)n/rn/rn/rn/r
HDM1005 injection dose level 2 (Part 1)n/rn/rn/rn/r
HDM1005 injection dose level 3 (Part 1)n/rn/rn/rn/r
HDM1005 injection dose level 4 (Part 1)n/rn/rn/rn/r
Experimental: HDM1005 injection one dose level with stepwise titration from a lower dose (Part 2)n/rn/rn/rn/r

Not shown

  • HDM1005 injection dose level 1(Part 1): endpoint not reported
  • HDM1005 injection dose level 2 (Part 1): endpoint not reported
  • HDM1005 injection dose level 3 (Part 1): endpoint not reported
  • HDM1005 injection dose level 4 (Part 1): endpoint not reported
  • Experimental: HDM1005 injection one dose level with stepwise titration from a lower dose (Part 2): endpoint not reported